Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARVINAS, INC. | Director | Stock Option (right to buy) | 10.2K | $163K | $16.00 | Jun 16, 2022 | Direct |
Passage BIO, Inc. | Director | Director Stock Option (Right to Buy) | 16.9K | May 27, 2021 | Direct | ||
Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 12, 2024 | Direct | ||
Eliem Therapeutics, Inc. | Director | Stock Option (Right To Buy) | 10K | Jun 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELYM | Eliem Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director |
IRON | Disc Medicine, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
IRON | Disc Medicine, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
ELYM | Eliem Therapeutics, Inc. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
IRON | Disc Medicine, Inc. | Dec 29, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Director |
IRON | Disc Medicine, Inc. | Dec 29, 2022 | 0 | $0 | 3 | Jan 3, 2023 | Director |
ARVN | ARVINAS, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
ELYM | Eliem Therapeutics, Inc. | May 19, 2022 | 1 | $0 | 4 | Jun 1, 2022 | Director |
ARVN | ARVINAS, INC. | Dec 14, 2021 | 8 | -$23.8M | 4 | Dec 16, 2021 | Director |
ARVN | ARVINAS, INC. | Nov 10, 2021 | 13 | -$11.5M | 4 | Nov 15, 2021 | Director |
ARVN | ARVINAS, INC. | Nov 5, 2021 | 22 | -$15.5M | 4 | Nov 9, 2021 | Director |
ELYM | Eliem Therapeutics, Inc. | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | Director |
ELYM | Eliem Therapeutics, Inc. | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | Director |
ARVN | ARVINAS, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
PASG | Passage BIO, Inc. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |